Reaction Details Report a problem with these data
Target
Histone H3.1
Ligand
BDBM50248522
Substrate
n/a
Meas. Tech.
Histone H3 Acetylation Assay
EC50
500±n/a nM
Citation
 Chen, D; Song, HY; Sun, ET; Yu, N; Zou, Y Benzimidazole derivatives: preparation and pharmaceutical applications US Patent  US10201527 Publication Date 2/12/2019 
Target
Name:
Histone H3.1
Synonyms:
H31_HUMAN | H3C1 | H3FA | H3FB | H3FC HIST1H3C | H3FD | H3FF | H3FH | H3FI | H3FJ | H3FK | H3FL | HIST1H3A | HIST1H3B | HIST1H3D | HIST1H3E | HIST1H3F | HIST1H3G | HIST1H3H | HIST1H3I | HIST1H3J
Type:
Enzyme Catalytic Domain
Mol. Mass.:
15425.07
Organism:
Homo sapiens (Human)
Description:
n/a
Residue:
136
Sequence:
MARTKQTARKSTGGKAPRKQLATKAARKSAPATGGVKKPHRYRPGTVALREIRRYQKSTELLIRKLPFQRLVREIAQDFKTDLRFQSSAVMALQEACEAYLVGLFEDTNLCAIHAKRVTIMPKDIQLARRIRGERA
  
Inhibitor
Name:
BDBM50248522
Synonyms:
CHEMBL489332 | N-hydroxy-3-(2-phenethyl-1-(2-(piperidin-1-yl)ethyl)-1H-benzo[d]imidazol-5-yl)acrylamide | US10201527, Compound 67 | US10736881, Compound 67 | US8551988, 67
Type:
Small organic molecule
Emp. Form.:
C25H30N4O2
Mol. Mass.:
418.5313
SMILES:
ONC(=O)\C=C\c1ccc2n(CCN3CCCCC3)c(CCc3ccccc3)nc2c1
Structure:
Search PDB for entries with ligand similarity: